Chris Leiter is a MBA Candidate 2021 and Sloan Fellow at the MIT Sloan School of Management, and an associate of the MIT Biotech Group and MIT Hacking Medicine Initiative. Prior to MIT, Chris was VP of Digital Health at Guardtime and Co-Founder of Guardtime Health, a blockchain enabled life sciences R&D platform, where he led on product management, partnerships and sales. Previously, he was a venture partner for a Swiss multi-family office, investing in early stage biotech and digital health technologies across Europe and North America. Chris began his career as a management consultant at KPMG based in London, where he founded the firm’s Global Healthtech group and was the Global Executive & COO of KPMG’s Global Healthcare Practice. Chris is a co-founder and board member of Series Q, supporting LGBTQ entrepreneurs and is an advisor to Gaingels, investing in seed through pre-IPO start-ups with LGBTQ founders or senior leadership.